No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm

Melanoma Research

Volumn 11, Issue 3, 2001, Pages 303-307

  Statius Muller, M G ^a   Van Leeuwen, P A M ^a   Van Diest, P J ^a   Vuylsteke, R J C L M ^a   Pijpers, R ^a   Meijer, S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breslow thickness; Cut off point; Melanoma; Nodal involvement; Regional node basin; Sentinel node

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CHILD; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; THICKNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY;

EID: 0034954775     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200106000-00013     Document Type: Article

References (24)

1. Recurrent malignant melanoma: The identification of prognostic factors to predict survival
2. Surgical management of regional lymph nodes in patients with melanoma
3. Minimal-access surgery for staging of malignant melanoma
4. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy
5. The sentinel node procedure in cutaneous melanoma: An overview of 6 years' experience
6. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion
7. Sentinel node localisation: A new prospective in the treatment of nodal melanoma metastases
8. Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients
9. Sentinel node metastasis from thin melanomas with vertical growth phase
10. Cutaneous melanomas that defy conventional prognostic indicators
11. Cutaneous melanomas exhibiting unusual biologic behavior
12. Incidence of sentinel node metastasis in patients with thin primary melanoma (≤ 1 mm) with vertical growth phase
13. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
14. Reliability of the sentinel node procedure in melanoma patients: Analysis of failures after long-term follow-up
15. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial
16. Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma
17. Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept
18. The role of elective lymph node dissection in malignant melanoma: Who should undergo this nodal staging procedure?
19. Sentinel lymphadenectomy for melanoma - Is it a substitute for elective lymphadenectomy?
20. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients
21. Molecular staging of malignant melanoma: Correlation with clinical outcome
22. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes
23. Recurrence potential of thin primary melanomas
24. Are loco-regional cutaneous metastases in melanoma predictable?